Skip to content

Randomised evaluation of assertive community treatment (REACT) services in London

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN55715361
Enrollment
251
Registered
2003-09-12
Start date
1999-11-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental and Behavioural Disorders Mental and Behavioural Disorders

Interventions

Interviews. Randomised Controlled Trial: A. Assertive Community Treatment B. Normal Care

Sponsors

Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Living in independent or low supported accommodation within the London boroughs of Camden and Islington 2. Under the care of the community mental health team for at least 12 months 3. Identified as having difficulty engaging with standard community care 4. Primary diagnosis of serious mental illness (for example, schizophrenia, schizoaffective disorder, other chronic psychosis, bipolar affective disorder) 5. Recent high use of inpatient care (at least 100 consecutive inpatient days or at least five admissions within the past two years or at least 50 consecutive inpatient days or at least three admissions within the past year) 6. Individuals with concurrent problems from substance misuse or personality disorder were eligible if these were secondary diagnoses

Exclusion criteria

Exclusion criteria: Patients with organic brain damage

Design outcomes

Primary

MeasureTime frame
Assertive Community Treatment (ACT) is an important and promising model, in that it has the potential to meet the needs of a particularly chaotic client group to whom standard community based services currently struggle to deliver services. The results should inform policy makers, local service commissioners and providers of health services in metropolitan areas in the UK.

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026